Jane Street Group LLC Decreases Stake in Senseonics Holdings, Inc. (NYSE:SENS)

Jane Street Group LLC trimmed its position in shares of Senseonics Holdings, Inc. (NYSE:SENS - Free Report) by 82.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 90,060 shares of the company's stock after selling 416,310 shares during the period. Jane Street Group LLC's holdings in Senseonics were worth $31,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of SENS. Symmetry Partners LLC bought a new stake in Senseonics in the third quarter valued at $164,000. Cubist Systematic Strategies LLC boosted its stake in shares of Senseonics by 25.9% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company's stock valued at $166,000 after purchasing an additional 85,501 shares in the last quarter. GSA Capital Partners LLP purchased a new position in shares of Senseonics during the third quarter valued at about $117,000. Finally, FMR LLC raised its stake in Senseonics by 48,267.2% in the third quarter. FMR LLC now owns 168,318 shares of the company's stock worth $59,000 after buying an additional 167,970 shares in the last quarter. 12.36% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have weighed in on the company. StockNews.com assumed coverage on Senseonics in a research report on Thursday, December 26th. They set a "sell" rating on the stock. HC Wainwright reaffirmed a "buy" rating and issued a $2.00 price target on shares of Senseonics in a research note on Friday, November 15th.

Remove Ads

Insiders Place Their Bets

In related news, CEO Timothy T. Goodnow purchased 315,000 shares of the stock in a transaction dated Tuesday, December 10th. The stock was purchased at an average price of $0.31 per share, with a total value of $97,650.00. Following the transaction, the chief executive officer now directly owns 11,310,355 shares in the company, valued at $3,506,210.05. This trade represents a 2.86 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Frederick T. Sullivan acquired 124,933 shares of the business's stock in a transaction that occurred on Thursday, December 12th. The shares were purchased at an average cost of $0.38 per share, for a total transaction of $47,474.54. Following the completion of the transaction, the chief financial officer now directly owns 2,478,844 shares in the company, valued at $941,960.72. The trade was a 5.31 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 3.60% of the company's stock.

Senseonics Stock Down 3.1 %

Shares of Senseonics stock traded down $0.03 during trading on Friday, hitting $0.85. The company's stock had a trading volume of 19,194,292 shares, compared to its average volume of 25,440,539. Senseonics Holdings, Inc. has a 52 week low of $0.25 and a 52 week high of $0.93. The company has a market capitalization of $504.78 million, a PE ratio of -6.52 and a beta of 0.64. The company has a fifty day simple moving average of $0.43 and a two-hundred day simple moving average of $0.40. The company has a debt-to-equity ratio of 59.17, a quick ratio of 2.38 and a current ratio of 2.47.

Senseonics Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.